搜尋結果
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says
Reuters· 7 小時前, opens new tab on Friday said its popular weight-loss drug Zepbound helped resolve moderate to ...
Martinez demands focus as Portugal brace for Turkish storm
Reuters· 7 小時前Aware of the challenge posed by playing a confident Turkey side enjoying virtual home ...
Ron Insana: Never mind the narrow leadership. This is a powerful bull market
CNBC· 7 小時前It's true that market leadership is narrow and a handful of tech and artificial ...
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of ...
CNBC· 7 小時前Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the ...
Securities are in the eye of the beholder
TechCrunch· 7 小時前The U.S. Securities and Exchange Commission has brought down its wrath on Coinbase. The publicl ...
Tedesco feels no fear as misfiring Belgium face Romania test
Reuters· 7 小時前Belgium will be without defender Axel Witsel for their European Championship Group E meeting ...
Poland missed moment with late Lewandowski introduction, says coach
Reuters· 8 小時前Poland coach Michal Probierz said the team had missed its moment when all-time top scorer ...
Tesla makes Musk best-paid CEO of all time and Fisker bites the dust
TechCrunch· 8 小時前Elon Musk just convinced Tesla shareholders to approve his $56 billion pay package, making him ...
First, Do No Harm: How Bioethics Can Inform Technology Ethics
The Wall Street Journal· 8 小時前More than a decade later, following postdoctoral research in health care systems delivery ...
If you’re grabbing tax-free income from this asset, you may be sacrificing yield
CNBC· 8 小時前This week, Wells Fargo Investment Institute highlighted the attraction of muni bonds as the ...